Purple Biotech Ltd. American Depositary Shares (PPBT)
Stock · NASDAQ · Health Care
$1.15as of 10/16/2026
Price chart
Active signals
PPBT Signal Track Record
How signals performed across all stocks →What PPBT's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band BreakdownActive now | 26 | -8.2% | 31% | July 13, 2026 |
| Bollinger Band Breakout | 16 | -10.7% | 31% | August 26, 2026 |
| Volume Spike | 10 | -7.1% | 20% | September 2, 2026 |
| 200-Day Moving Average TouchActive now | 4 | -14.5% | 0% | October 20, 2023 |
| Any 20-session window (baseline) | -8.8% | 31% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About PPBT
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks the interactions of carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 2 clin…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 10
- Website
- purple-biotech.com/
Fundamentals
- 1-day range
- $1.13$1.29
- Market cap
- $2.29M
- P/E (trailing)
- —
- P/E (forward)
- -1.13
- EPS (trailing)
- $-0.01
- Dividend yield
- —
- Beta
- 0.12
- Avg. volume
- 1.28M
- Dividend pay date
- August 21, 2020
Forecasts
1 analyst ratings
Purple Biotech Ltd. American Depositary Shares Competitors
Chosen by industry and closest market cap.
- PPBTPurple Biotech Ltd. American Depositary Shares$1.14▼ 7.32%Market cap $2.29MP/E —$1$2.2
- GNPXGenprex Inc. Common Stock$2.11▼ 7.86%Market cap $2.24MP/E —$2.53$1,210
- DCOYDecoy Therapeutics Inc. Common Stock$1.17▼ 4.88%Market cap $2.40MP/E —$2.01$55.92
- AZTRAzitra Inc Common Stock$0.072▲ 0.00%Market cap $2.18MP/E 6.22$0.0518$1.09
- OGENOragenics Inc. Common Stock$0.43▼ 2.27%Market cap $2.45MP/E 0.56$0.43$1.45
- SXTCChina SXT Pharmaceuticals Inc. Class A Ordinary Shares$0.065▼ 5.80%Market cap $2.06MP/E —$0.0619$83,758
- CDTCDT Equity Inc. Common Stock$0.235▲ 12.44%Market cap $2.54MP/E —$0.1813$28,125
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| PPBT Purple Biotech Ltd. American Depositary Shares | $2.29M | — | $1.14 | ▼ 7.32% | $1$2.2 |
| GNPX Genprex Inc. Common Stock | $2.24M | — | $2.11 | ▼ 7.86% | $2.53$1,210 |
| DCOY Decoy Therapeutics Inc. Common Stock | $2.40M | — | $1.17 | ▼ 4.88% | $2.01$55.92 |
| AZTR Azitra Inc Common Stock | $2.18M | 6.22 | $0.072 | ▲ 0.00% | $0.0518$1.09 |
| OGEN Oragenics Inc. Common Stock | $2.45M | 0.56 | $0.43 | ▼ 2.27% | $0.43$1.45 |
| SXTC China SXT Pharmaceuticals Inc. Class A Ordinary Shares | $2.06M | — | $0.065 | ▼ 5.80% | $0.0619$83,758 |
| CDT CDT Equity Inc. Common Stock | $2.54M | — | $0.235 | ▲ 12.44% | $0.1813$28,125 |
P/E shows — for peers not currently carrying a live signal of their own.
Institutional Ownership
March 31, 2026
- Total shares held
- 75.7K
- Total value held
- $305.6K
- Institutional holders
- 15
- Unknown53.4K
- Unknown18.1K
- Unknown2.0K
- Unknown710
- Unknown597
- Unknown578
- Unknown108
- Unknown99
- Unknown31
- Unknown20
See the full, filterable feed with live charts on the MarketWall dashboard.